Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire March 17, 2020

Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results

Business Wire March 16, 2020

Pulse Biosciences Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 16, 2020

Business Wire March 9, 2020

Pulse Biosciences to Participate in the Cowen Health Care Conference

Business Wire February 19, 2020

Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology

Business Wire February 13, 2020

Pulse Biosciences to Present Data on Nano-Pulse Stimulation Technology for Nodular Basal Cell Carcinoma at IMCAS World Congress 2020

Business Wire January 29, 2020

Pulse Biosciences Updates on Regulatory Progress

Business Wire December 18, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire December 16, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire November 18, 2019

Pulse Biosciences Announces Transition of Chief Financial Officer

Business Wire November 7, 2019

Pulse Biosciences Quarterly Investor Conference Call

Business Wire November 7, 2019

Pulse Biosciences to Report Third Quarter 2019 Operational Highlights and Financial Results

Business Wire October 31, 2019

Pulse Biosciences Presents Data From Several Clinical Studies of Nano-Pulse Stimulation Technology(TM) to Clear Skin Lesions at the 2019 ASDS Annual Meeting

Business Wire October 17, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire October 15, 2019

Pulse Biosciences Announces Scientific Presentations of Nano-Pulse Stimulation(TM) Technology at Key Medical Aesthetic Meetings

Business Wire October 1, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire September 17, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire September 4, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire August 16, 2019

Pulse Biosciences Quarterly Investor Conference Call

Business Wire August 8, 2019

Pulse Biosciences Announces Podium Presentation of Nano-Pulse Stimulationâ„¢ Technology at Major Aesthetic Procedures Conference

Business Wire August 6, 2019